Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Ann Clin Microbiol Antimicrob ; 22(1): 72, 2023 Aug 11.
Artigo em Inglês | MEDLINE | ID: mdl-37568240

RESUMO

BACKGROUND: Sepsis represents a time-sensitive disease requiring early therapeutical intervention to avoid adverse patient outcomes. Rapid microbiological diagnosis is essential to investigate sepsis aetiological agents. The FAST™ system (Qvella, ON, Canada) provides a concentrated microbial suspension, known as a Liquid Colony™ (LC), directly from positive blood samples (PBCs) in 30-40 min to perform rapid identification (ID) and antimicrobial susceptibility testing (AST). METHODS: Qvella's FAST™ System and FAST PBC Prep cartridges were tested on PBCs from the Policlinico Hospital of Catania during a six-month study. Two millilitres of PBC were converted into an LC for rapid ID and AST using Bruker Biotyper Sirius MALDI and BD Phoenix systems. Standard of care (SOC) methods were used as a reference, requiring 48-72 h. Agreement between the innovative technology and the standard method was calculated. RESULTS: FAST System processing was performed on 100 monomicrobial PBCs. Median turnaround times from blood cultures flagging positive to ID and AST completion were 2 and 26 h respectively. Therefore, the LC procedure was 24 h faster than the median turnaround times for SOC methods. 100% ID identification concordance was observed across 48 Gram-negative bacteria, 42 Gram-positive bacteria and 11 yeast for the genus level. 78% of Gram-negative and 95% of Gram-positive bacteria were resistant to ≥ 2 antimicrobial agents, including 45% (15/33) carbapenem-resistant enteric Gram-negative bacteria and 90% (28/31) oxacillin-resistant staphylococci. An AST essential agreement of 100% was observed due to the absence of MIC discrepancies > 1-fold dilution. Categorical errors were not observed due to the absence of MIC categorization discordances. Yeast AST was not performed. CONCLUSIONS: The Qvella FAST System produces an LC that reliably reflects the MALDI spectra and phenotypic antimicrobial susceptibility profile of microbial cells growing in the blood culture. Timely processing of PBCs with the Qvella FAST System enables sepsis diagnostic confirmation 1 day sooner than the standard methods. In line with these results, it is vital now to focus attention on establishing best practices for incorporating this strategic tool into the clinical microbiology laboratory workflow.


Assuntos
Anti-Infecciosos , Bacteriemia , Sepse , Humanos , Hemocultura/métodos , Bacteriemia/tratamento farmacológico , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Testes de Sensibilidade Microbiana , Saccharomyces cerevisiae , Bactérias Gram-Negativas , Bactérias , Sepse/tratamento farmacológico , Bactérias Gram-Positivas
2.
Clin Otolaryngol ; 47(1): 14-23, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34599556

RESUMO

OBJECTIVES: We performed a systematic review on single-nucleotide polymorphisms and risk-related chronic rhinosinusitis. DESIGN AND SETTING: A comprehensive review of the last 20 years' English language literature regarding chronic rhinosinusitis and single-nucleotide polymorphisms was performed. We included in the synthesis all the papers reporting gene variation implicated in the pathogenesis of chronic inflammation and polyps. RESULTS: We found 12 papers with 9127 patients, of which 2739 CRS cases and 6388 controls. The major comorbidities reported related to chronic rhinosinusitis were atopy in 4555 (49.9%), asthma in 4594 (50.33%), Samter Triad in 448 (4.9%) and eosinophilia in 391 subjects (4.28%). CONCLUSION: Our systematic review revealed the major SNPs significantly associated with chronic rhinosinusitis and the specific pathways involved. Given the presence of different extraction methods and samples sequencing, further studies with larger courts are necessary to identify significative single-nucleotide polymorphisms.


Assuntos
Polimorfismo de Nucleotídeo Único , Rinite/genética , Sinusite/genética , Doença Crônica , Comorbidade , Predisposição Genética para Doença , Humanos
4.
Rev Sci Instrum ; 95(3)2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38451143

RESUMO

The Moons And Jupiter Imaging Spectrometer (MAJIS) is the visible and near-infrared imaging spectrometer onboard the European Space Agency (ESA)'s Jupiter Icy Moons Explorer mission. Before its integration into the spacecraft, the instrument undergoes an extensive ground calibration to establish its baseline performances. This process prepares the imaging spectrometer for flight operations by characterizing the behavior of the instrument under various operative conditions and uncovering instrumental distortions that may depend on instrumental commands. Two steps of the on-ground calibration campaigns were held at the instrument level to produce the data. Additional in-flight measurements have recently been obtained after launch during the Near-Earth Commissioning Phase. In this article, we present the analyses of these datasets, focusing on the characterization of the spectral performances. First, we describe and analyze the spectral calibration datasets obtained using both monochromatic sources and polychromatic sources coupled with solid and gas samples. Then, we derive the spectral sampling and the spectral response function over the entire field of view. These spectral characteristics are quantified for various operational parameters of MAJIS, such as temperature and spectral binning. The derived on-ground performances are then compared with in-flight measurements obtained after launch and presented in the framework of the MAJIS performance requirements.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA